TELIX (TLX) marked their (quick off the mark) announcement as PRICE SENITIVE. It's certainly more price sensitive for TLX coz they have a product in market, that was going to be affected as early as CY2025! [The new separate payment rule will apply to Illuccix® after its pass-through status expires, from July 1, 2025.] TLX also have other products that are expected to hit the market in the near term, so the mood should certainly get lifted a bit more by this announcement.
CLARITY (CU6) took longer to say something and decided the news was NOT PRICE SENSITIVE anyway. Their announcement is very future facing, with not just comments celebrating the event, but also shedding more light on how and who their products will disrupt in the market. Also mentioned is that the positive change makes the area a blockbuster product category!
"We look forward to bringing what we believe to be the best PSMA diagnostic ever made to market and disrupting the dynamics of current-generation products, i.e. PYLARIFY, generic 68Ga-PSMA-11 (sold as Locametz and Illuccix) and POSLUMA."
"Not only can we deliver clinical benefits associated with increasedproduct uptake and retention in lesions, but also improve patient access to PSMA PET imaging due to the 48-hour shelf-life of 64Cu-SAR-bisPSMA, enabled by the longer half-life of Cu-64. This means that, unlike short-lived 68Ga- and 18Fbased products, we can reach patients in broader geographic areas and help eliminate disparities in cancer diagnosis around the world."
The Cu6 announcement may not be Share-PRICE SENSITIVE (today) - but it's a potentially HUGE BOOST to how much we get in the event of a Buy Out! a) CU6 is more attractive to Big Pharma today than it was this time last week, due to the new situation of more certain and huge revenues ahead, even in diagnostics! Lantheus (makers of PYLARIFY) jumped on the news, and TLX is moving steadily too! b) CU6's potential Buy-Out price should be higher today than what it was when the likes of Fusion got bought! Everyone now knows of the huge revenues ahead (which did not apply during the Fusion et al buyouts)!
IN CONCLUSION: CU6 is a very GOOB BUY in my opinion. Not financial advice!
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)